MicroRNA‐483 amelioration of experimental pulmonary hypertension

Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit. Lower levels of miR‐483 were found in serum from patients with idiopathic pulmonary arterial hypertension (IPAH), part...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EMBO Mol Med
Main Authors: Zhang, Jin, He, Yangyang, Yan, Xiaosong, Chen, Shanshan, He, Ming, Lei, Yuyang, Zhang, Jiao, Gongol, Brendan, Gu, Mingxia, Miao, Yifei, Bai, Liang, Cui, Xiaopei, Wang, Xiaojian, Zhang, Yixin, Fan, Fenling, Li, Zhao, Shen, Yuan, Chou, Chih‐Hung, Huang, Hsien‐Da, Malhotra, Atul, Rabinovitch, Marlene, Jing, Zhi‐Cheng, Shyy, John Y‐J
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2020
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207157/
https://ncbi.nlm.nih.gov/pubmed/32324970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201911303
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares